The announcement on 7 August stated that the first patient had received the first dose of the drug. Presumably that was within a day or so of the release. The treatment period is 28 days with a possibility of an extension.
I would expect an update in early September about that patient, the recruitment of others and the general progress of the trial. Hopefully an announcement about the animal trial is not far off as well.
PPL-1 Cancer Trials, page-20
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.8¢ |
Change
-0.003(1.25%) |
Mkt cap ! $87.89M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.8¢ | 19.5¢ | $29.82K | 151.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 506946 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 803554 | 8 |
View Market Depth
| Last trade - 11.53am 10/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |